A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)

NCT06930664 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Sotatercept
BIOLOGICAL: Sotatercept Autoinjector

Sponsor

Merck Sharp & Dohme LLC